MIAMI, Feb. 08, 2021 (World NEWSWIRE) — 20/20 Global, Inc., (OTC Pink: TWGL) “Mycotopia”, a enterprise focused on psychedelic therapies, announced now that it has used to the Economical Business Regulatory Authority (“FINRA”) to improve the identify of the Company to Mycotopia Therapies Inc. The Enterprise has also submitted an software to FINRA to modify its stock symbol on OTC Market place, asked for image (MYCO).
The Organization is also working to safe DTC eligibility by The Depository Belief Corporation (“DTC”) for digital settlement and transfer of its frequent shares in the United States. There is no motion required by current shareholders in link with any of these changes.
“Our identify and symbol adjust are both in line with our strategic changeover into the emerging area of psychedelics,” reported 20/20 World-wide CEO, Ben Kaplan. “We believe that it is in the ideal desire of our shareholders to rebrand our organization to mirror our purpose of offering psychedelic therapies by technologies-concentrated, info-pushed, and clinical-primarily based alternatives for people working with nervousness, despair, bipolar ailments, PTSD, ADHD, autism, and addictions.”
The Firm’s web-site is accessible at https://www.mycotopiatherapies.com.
About 20/20 World and Mycotopia Treatment
Mycotopia Therapies Inc. presents psychedelic therapies by way of technology-centered, details-pushed, and health care-based remedies for individuals dealing with stress, despair, bipolar issues, PTSD, ADHD, autism, and addictions. With a primary concentrate of supporting you recover and reclaim your everyday living, Mycotopia Treatment endeavors to guideline persons via their journey of therapeutic. This is accomplished by getting an comprehending of the results in and is effective to psychological wellness through psychedelic increased psychotherapy, built-in with a skilled workforce of mental wellness practitioners and chopping-edge technological know-how. Psychedelic remedy is a holistic and religious solution furnishing healing and has shown productive procedure for several several years. The organization operates as a subsidiary of EHAVE, Inc. (EHVVF). Extra info on Mycotopia Remedy can be located on the Company’s web site at: https://www.mycotopiatherapies.com.
Ahead-On the lookout Statement Disclaimer
This push release has “forward-searching statements” inside the this means of the Private Securities Litigation Reform Act of 1995. These kinds of statements might be preceded by the words “intends,” “may,” “will,” “plans,” “expects,” “anticipates,” “projects,” “predicts,” “estimates,” “aims,” “believes,” “hopes,” “potential” or similar terms. Forward-looking statements are dependent on specific assumptions and are matter to different recognised and unknown risks and uncertainties, lots of of which are past the Company’s management, and simply cannot be predicted or quantified and as a result, genuine outcomes could differ materially from individuals expressed or implied by such forward-hunting statements: (i) the initiation, timing, progress and final results of the Company’s exploration, manufacturing and other development attempts (ii) the Company’s skill to advance its merchandise to properly entire enhancement and commercialization (iii) the manufacturing, growth, commercialization, and industry acceptance of the Company’s solutions (iv) the absence of ample funding to finance the product advancement and company functions (v) aggressive providers and systems inside of the Company’s field and introduction of competing merchandise (vi) the Company’s ability to build and retain corporate collaborations (vii) loss of vital management staff (viii) the scope of defense the Business is capable to build and sustain for intellectual residence legal rights masking its goods and its means to work its company with no infringing the intellectual property legal rights of other individuals (ix) likely failure to comply with applicable health information privateness and security laws and other state and federal privateness and stability laws and (x) the difficulty of predicting actions of the Usa Food and drug administration and its rules. All ahead-looking statements provided in this press release are built only as of the day of this push release. The Enterprise assumes no obligation to update any published or oral ahead-wanting assertion except if demanded by legislation. Additional comprehensive information about the Enterprise and the chance variables that could influence the realization of ahead-on the lookout statements is contained underneath the heading “Danger Factors” in 20/20 World, Inc.’s Registration Statement on Type F-1 submitted with the Securities and Trade Fee (SEC) on September 24, 2015, as amended, which is readily available on the SEC’s web site, https://www.sec.gov.
Speak to for 20/20 Worldwide and Ehave
Investor Relations and Media Inquiries: Gabe Rodriguez
E mail: [email protected]
Cell phone: (623) 261-9046